(IN BRIEF) Basilea Pharmaceutica Ltd (SIX: BSLN), a biopharmaceutical company specializing in severe bacterial and fungal infection treatments, has announced an asset purchase agreement with Spexis AG (SIX: SPEX) for a preclinical antibiotics program aimed at combating Gram-negative bacteria, including … Read the full press release
(IN BRIEF) Sandoz, a global leader in generic and biosimilar medicines, has signed a Memorandum of Understanding to build a new biologics production plant in Lendava, Slovenia, in a move expected to be worth at least USD 400 million. The … Read the full press release
Posted in Business, Financial, Healthcare, Investment, Management, News, Pharma & Biotech, Science, Switzerland
Tagged antibiotics, Biologics Plant, Dr Robert Golob, Glenn Gerecke, investment, Lendava, Novartis, partnership, Richard Saynor, Sandoz, Slovenia
(PRESS RELEASE) AMERSFOORT, 10-Aug-2021 — /EuropaWire/ — Nutreco, leading company in the field of animal nutrition and aquafeed, has announced it is leading a EUR 21 million financing round together with Aqua-Spark and PFR Life Science, a portfolio company of … Read the full press release
Posted in Agriculture, Artificial Intelligence (AI), Environment, Investment, Netherlands, News, Pharma & Biotech, Poland, Technology
Tagged Aeromonas, AHPND, AI, Amy Novogratz, Angel investors, antibiotics, Aqua-Spark, aquaculture, Avian Pathogenic E. Coli, bacteriophages, climate goals, environmental sustainability, farmers, GHG emission, investment, Jarosław Dastych, Laëtitia Gerbe, livestock farming, Mastitis, Matthew Tebeau, Mike Velings, Montis Capital, Nutreco, Paweł Borys, PFR, PFR Life Science, Polish Development Fund, protein production, Proteon Pharmaceuticals, Pseudomonas, Rob Koremans, Salmonella, Seventure Partners, Skretting, soil pollution, sustainability, water pollution, Wojciech Szwankowski
(PRESS RELEASE) BILBAO, 5-Jan-2021 — /EuropaWire/ — BBVA announces that Yesil Science, a company participating in Garanti BBVA Partners program has launched a mobile health application supported by artificial intelligence, FluAI. FluAI is specifically intended for upper respiratory tract infections, … Read the full press release
Posted in Artificial Intelligence (AI), Healthcare, News, Science, Spain, Technology, Turkey
Tagged AI, AI assisted flu assistant, AIFD, antibiotics, artificial-intelligence, colds, coronavirus, flu, FluAI, Garanti BBVA Partners, Green Science, health, Istanbul Chamber of Industry, Joseph Green, mobile health app, NVIDIA, science and technology, technology, Technopark Istanbul, TÜSİAD, upper respiratory tract infections, Yesil Science
Deflux.com/UK provides valuable information regarding vesicoureteral reflux (VUR); connects parents and caregivers of children with VUR with paediatric urologists (PRESS RELEASE)SANTA BARBARA, CALIF., U.S.A. / STOCKHOLM SWEDEN, 4-Aug-2020 — /EuropaWire/ — Palette Life Sciences, a fully integrated global life sciences company … Read the full press release
Posted in Education, Healthcare, News, Pharma & Biotech, Sweden, United Kingdom
Tagged antibiotics, biocomopatible treatment, bladder reflux, caregivers, Chelsea and Westminster Hospital, Deflux.com/UK, Deflux®, dextranomer, dextranomer polysaccharides, Dr. Marie-Klaire Farrugia, Dx, HA, hyaluronic acid, interventional oncology procedures, microspheres, NASHA®, Non-Animal Stabilised Hyaluronic Acid, online resource, paediatric urinary condition, paediatric urologists, paediatric urology, Palette Life Sciences, polysaccharides, reducing VUR, Rich Low, urinary, urine refluxes, urogynaecology disorders, urology, UTI recurrence, vesicoureteral reflux, VUR
LEEDS, 26-8-2014 — /EuropaWire/ — A revolutionary new scientific method developed at the University of Leeds will improve the diversity of ‘biologically active molecules’, such as antibiotics and anti-cancer agents. The researchers, who report their findings online today in the journal Nature Chemistry, took … Read the full press release
EuropaWire (EW) is the first truly pan-European and leading press release distribution and newswire service for Europe and the European Union working towards consolidating Europe’s voice on the global newswire and media scene. The newswire service comes with advanced submission forms, flexible pricing and PR budgeting, granular targeting, nearly uncapped reach across countries, markets, verticals, industries, audiences, languages, etc., translation and localisation for greater local PR impact, in-depth distribution reporting, metrics and insights including measured PR reach, reads, engagements, impact, etc., no cap on words, images and multimedia to go along with your release, among others. Your press releases will be seen among the releases of Europe’s biggest and most prominent companies, brands and institutions.
HOW TO GET STARTED?
PHARMA & BIOTECH: The largest repository of EU/European pharma & biotech press releases spanning 12 years (2012-2024)
